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The commonest myth about science
in the media is that journalists are
interested only in doom and disaster.
The second commonest is that rare
reports of good news are invariably
ruined by error and sensationalism.
The UK media on 10 March
provided ample evidence to explode
these myths simultaneously. The
occasion was the publication of two
closely linked papers (Science 2000,
287:1809-1815 and 1816-1820)
concerning Neisseria meningitidis
serotype B. The first — by
researchers in Rockville in Maryland,
Oxford and Siena — reported the
organism’s complete genome
sequence. The second, from these
and other centres, described studies
on several surface-exposed proteins,
conserved in a range of strains, which
have been tested as the possible
basis for a vaccine.
Such was the level of media
interest in these announcements that
one of the Oxford authors, Richard
Moxon, appeared live on both BBC
Breakfast News and (20 minutes later)
GMTV to discuss their implications.
Each programme gave him enough
time to explain precisely what had,
and had not, been achieved. In
neither case did the interviewer put
him under pressure to exaggerate the
imminence of a vaccine against this
form of meningitis.
Newspapers showed appropriate
caution, too, in some cases by placing
the story inconspicuously on an
inside page. Thus the Daily Telegraph
reported that publication of the
genetic blueprint “showed how the
‘genomic revolution’ will fuel
medical advances.” The
collaborative research team had
“found seven surface proteins which
can stimulate an antibody response
capable of killing the bacterium, and
are trying to identify the most
promising vaccine candidates.”
Even papers that produced
longer, more prominent accounts
took considerable care not to raise
premature hopes among their
readers. Writing on the front page of
the Daily Mail, for example, science
correspondent James Chapman
explained: “researchers are
confident they can use the genetic
information to produce a vaccine.
Though that could be four or five
years away, tests in mice have
already suggested that it will be
effective.” Chapman continued,
“Scientists say mapping the bug’s
genes revealed crucial chinks in its
armour, hitherto unknown proteins
on its surface which could be used in
a vaccine to stimulate the antibody
response.” This is hardly the stuff of
hype or irresponsibility.
Why did an Oxford professor
discussing genome sequencing
get top billing on breakfast TV?
So what propelled this piece of
arcane molecular biology, with its
distant promise of immunisation, into
the headlines? Why did the editor of
GMTV (a programme whose staple
diet is soap opera stars, football
managers and mumbo-jumbo on
health) give top billing instead to an
Oxford professor discussing genome
sequencing? Part of the answer is that
meningitis is one of those infections
which, for obvious reasons, attracts
the attention of news editors. Most
would also have recalled that only last
autumn saw the introducton into the
UK of a vaccine against
meningitis C — which, nevertheless,
accounts for only 40% of cases.
Research that could lead to a
meningitis B vaccine to prevent
the remaining 60% of infections is
clearly newsworthy.
Probably the crucial factor,
however, was the fact that a press
release about the 2,272,351 base-pairs
of the meningococcus arrived in
editorial offices on exactly the same
day as news of a human tragedy. Tyler
Foster, aged 23 months, had died of
meningitis after being moved on a
long journey between three different
medical centres. The entire chain of
events took 10 hours.
This was the fortuitous
combination of scientific and human
interest that the Daily Mail
highlighted through two parallel
articles occupying its entire front page
and much of page two. The Times also
ran “Meningitis boy faced 90-mile
transfer ordeal” alongside “Vaccine on
way to beat deadly strain.”
There is a third myth concerning
media handling of advances in
science and medicine. It is that
tabloid newspapers are the worst of
the worst, getting most things wrong
and trivialising or sensationalising
everything. Although there is
occasional truth in these accusations,
they are often belied by reality.
On this occasion, it would be hard
to beat the short piece by the
medical correspondent of the Mirror,
Jill Palmer. “An end to the terror of
meningitis may be in sight thanks to
a new vaccine being developed,” she
wrote. “Scientists have cracked the
genetic code for the bug which
causes meningitis B — the most
deadly form — and the associated
blood poisoning. Research has
revealed chinks in the bacteria’s
armour, proteins which might be
used to develop a vaccine.”
In a remarkably tight précis,
Palmer also recorded the 1,530 UK
deaths attributed to meningitis B last
year, reminded readers of the recent
introduction of meningitis C vaccine
and gave the researchers’ locations.
She ended by citing one expert’s
prediction that immunisation against
the B serotype was five years away. 
This is not exactly irresponsible
hackery. Habitual critics of the
media, please note.
Bernard Dixon is a freelance science writer
based in Middlesex, UK.
R288 Current Biology Vol 10 No 8
bb10h71.qxd  04/17/2000  12:54  Page R288
